Aria Olumi
Chief of Urologic Surgery at Beth Israel Deaconess Medical Center · Beth Israel Deaconess Medical Center
Credentials: · · ·
History
- Present
Urologic Surgery at Beth Israel Deaconess Medical Center Division
- Present
Janet & William DeWolf Professor of Surgery/Urology at Harvard Medical School Division · Beth Israel Deaconess Medical Center
- Present
Urology Division · Beth Israel Deaconess Medical Center
- 1994–1999
Urology
Research
Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium
Cancer Research · 1999 · First of 6 authors · 1,277 citations
5-Methylcytosine as an endogenous mutagen in the human LDL receptor and p53 genes
Science · 1990 · 574 citations
Cell Metabolism · 2013 · 286 citations
34 papers · 1 as a resident
24 papers
23 papers
- CW
23 papers
17 papers
13 papers
12 papers · 12 as a resident
- RG
12 papers · 3 as a resident
Grants
- 2024–2029
New Treatment Strategies and Epigenetic Biomarker for Management of BPH
National Institute of Diabetes and Digestive and Kidney Diseases · R01
Contact PI · $1.8M · Beth Israel Deaconess Medical Center
- 2024–2028
Decreased SRD5A2 and Alternative Estrogen Signaling in Prostatic Cell Survival
National Institute of Diabetes and Digestive and Kidney Diseases · R01
Contact PI · $2M · Beth Israel Deaconess Medical Center
- 2020–2026
SRD5A2 as a Marker of Resistance to 5ARI Therapy
National Institute of Diabetes and Digestive and Kidney Diseases · R01
Contact PI · $1.8M · Beth Israel Deaconess Medical Center
- 2019–2020
National Institute of Diabetes and Digestive and Kidney Diseases · R13
Contact PI · $10K · American Urological Association
Clinical trials
- 2025–2030
New Treatment Strategies and Epigenetic Biomarker for Management of Benign Prostatic Hyperplasia
Principal investigator · Recruiting · Phase 2
Beth Israel Deaconess Medical Center
- 2020–2026
5-Alpha Reductase 2 as a Marker of Resistance to 5ARI Therapy
Principal investigator · Recruiting
Beth Israel Deaconess Medical Center